 |
|
Home | Pfizer Given New $31.00 Price Target at Morgan Stanley (PFE) |
 |
Pfizer Given New $31.00 Price Target at Morgan Stanley (PFE)
|
 |
- March 07, 2013
-
Morgan Stanley increased their price target on shares of Pfizer (NYSE: PFE) to $31.00 in a research note issued on Thursday. The analysts wrote, “Pfizer’s FCF yield is attractive at 8%. Raising PT from $27 to $31 based upon greater long-term pipeline contribution and thus more optimistic DCF (changed terminal growth from -3% to -2%). [...]This article (Pfizer Given New $31.00 Price Target at Morgan Stanley (PFE)) was originally developed by and is property of American Banking News.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
- Read more at:http://www.americanbankingnews.com/2013/03/07/pfizer-given-new-31-00-price-target-at-morgan-stanley-pfe/
|
 |
|
 |
|
 |
